| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/27/2009 | US7482010 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482009 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482005 Methods of treating diseases with anti-VEGF antibodies |
| 01/27/2009 | US7482004 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482002 Method of administering and using VEGF inhibitors for the treatment of prostate cancer |
| 01/27/2009 | US7482001 Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer |
| 01/27/2009 | US7481999 Compounds and methods for modulating OB-cadherin-mediated function |
| 01/27/2009 | US7481998 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 01/27/2009 | US7481995 Aerosol composition |
| 01/27/2009 | US7481993 conjugate PT comprising(a) a peptide P and(b) a targeting moiety T;wherein the peptide P contains from 4 to 20 amino acid residues with optionally a single thiol moiety at the C- or N-terminus replacing one of these amino acid residues, and including a complexing amino acid sequence |
| 01/27/2009 | US7481790 Vessel enlargement by arteriogenic factor delivery |
| 01/27/2009 | CA2540439C Low frequency vibration assisted blood perfusion emergency system |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/27/2009 | CA2411786C A process for the preparation of polypeptides from n-carboxyanhydrides of amino acids |
| 01/27/2009 | CA2354034C Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/27/2009 | CA2332038C Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 01/27/2009 | CA2309653C Use of protein h as cytostatic agent |
| 01/27/2009 | CA2296669C Nutritional composition for the treatment of pressure ulcers |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2259619C Cytochrome p450 expression in enterobacteria |
| 01/27/2009 | CA2235372C Method for treating ischemic tissue |
| 01/27/2009 | CA2196339C Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/27/2009 | CA2151613C Osseointegration promoting implant composition, implant assembly and method therefor |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/22/2009 | WO2009012472A2 Methods and compositions for treating conditions |
| 01/22/2009 | WO2009012460A1 Survivin peptides as cancer vaccines |
| 01/22/2009 | WO2009012443A1 Nanoparticles for the elution of growth factors for recovery and regeneration of organs |
| 01/22/2009 | WO2009012400A2 Orally administered peptides to improve or prevent hepatic fibrosis |
| 01/22/2009 | WO2009012224A2 Peptide-based regulation of gap junctions |
| 01/22/2009 | WO2009012173A2 Enhanced biotherapeutic production using inhibitory rna |
| 01/22/2009 | WO2009012166A1 Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
| 01/22/2009 | WO2009012143A2 Virus derived antimicrobial peptides |
| 01/22/2009 | WO2009011988A2 Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth |
| 01/22/2009 | WO2009011893A2 Treatments of b-cell proliferative disorders |
| 01/22/2009 | WO2009011883A1 Compositions and methods for wound healing |
| 01/22/2009 | WO2009011795A2 Methods for treating stress induced emotional disorders |
| 01/22/2009 | WO2009010968A2 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | WO2009010874A2 Preprocalcitonin antigen t epitopes |
| 01/22/2009 | WO2009010804A1 Macrocyclic compounds as antiviral agents |
| 01/22/2009 | WO2009010765A2 Lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010763A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010733A2 Peptide gap junction modulators |
| 01/22/2009 | WO2009010611A1 Polypeptides derived from psap protein (presenilin 1 - associated protein) capable of causing apoptosis and uses of the same |
| 01/22/2009 | WO2009010540A1 New polypeptides inducing apoptosis and uses thereof |
| 01/22/2009 | WO2009010428A1 Protease stabilized, pegylated insulin analogues |
| 01/22/2009 | WO2009010409A1 Novel inhibitor of angiogenesis |
| 01/22/2009 | WO2009010398A1 Stabilized prolactin receptor antagonists |
| 01/22/2009 | WO2009010392A1 Agents containing proteases from stenotrophomonas maltophilia |
| 01/22/2009 | WO2009010287A2 Specific therapy and medicament using integrin ligands for treating cancer |
| 01/22/2009 | WO2009010121A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | WO2009010107A1 Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis |
| 01/22/2009 | WO2009010071A1 Osteopontin nanoparticles system for drug delivery |
| 01/22/2009 | WO2009010045A1 Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains |
| 01/22/2009 | WO2009009907A1 Use of vasopressin-receptor agonists for the treatment of septic shock |
| 01/22/2009 | WO2009009829A1 Method for reducing intracranial pressure |
| 01/22/2009 | WO2008148023A3 Compositions and methods for treating neurological disorders |
| 01/22/2009 | WO2008144590A3 Long lasting modified antifusogenic peptide for preventing hiv infection |
| 01/22/2009 | WO2008135207A8 Implantable system for an intervertebral disc and intervertebral disc implant |
| 01/22/2009 | WO2008121830A3 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 01/22/2009 | WO2008052567A3 Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor |
| 01/22/2009 | WO2008035371A3 Dietary anti-bacterial compositions |
| 01/22/2009 | WO2008026075A3 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator |
| 01/22/2009 | WO2008014400A8 Crohn disease susceptibility gene |
| 01/22/2009 | US20090025098 Hepatitis C receptor protein CD81 |
| 01/22/2009 | US20090023893 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 01/22/2009 | US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate |
| 01/22/2009 | US20090023699 Method For Obtaining a Natural Mixture of Conjugated Equine Estrogens Depleted in Non-Conjugated Lipophilic Compounds |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023663 Thymosin beta 4 compositions and methods |
| 01/22/2009 | US20090023662 recognize extracellular structures of G protein-coupled receptors; for treating humoral kidney rejection |
| 01/22/2009 | US20090023661 Use of Antagonists of the Bradykinin B2 Receptor for the Treatment of Osteoarthrosis |
| 01/22/2009 | US20090023660 Novel Hemopoietin Receptor Protein, NR12 |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023658 Neovascularization Inhibitors Derived From HGF and Methods Involving the Same |
| 01/22/2009 | US20090023657 Catecholamine regulated protein |
| 01/22/2009 | US20090023656 Combretastatin A4, ombrabulin hydrochloride, or 1-(3-amino-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene with VEGF inhibitor fusion protein VEGF Trap |
| 01/22/2009 | US20090023655 Biased Ligands for Receptors Such as the PTH Receptor |
| 01/22/2009 | US20090023652 Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| 01/22/2009 | US20090023651 Inhibitors of human plasmin derived from the kunitz domains |
| 01/22/2009 | US20090023650 Treatment of egfr-dependent tumors by abin (a20 -binding inhibitor of nf kappab) |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023648 Methods for Treating Body Tissue |
| 01/22/2009 | US20090023647 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 01/22/2009 | US20090023646 GHRH analogues |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023644 Methods of using cgrp for cardiovascular and renal indications |
| 01/22/2009 | US20090023643 Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same |
| 01/22/2009 | US20090023642 Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A |
| 01/22/2009 | US20090023641 Cyclic Antimicrobial Peptides |
| 01/22/2009 | US20090023640 Use Of A Cyclic Undecapeptide For The Preparation Of A Medicament For Administration During Myocardial Ischaemic Events |
| 01/22/2009 | US20090023639 Methods of Treatment |